Eli Lilly and Company Unveils Expanded Biotechnology Center in San Diego

Thursday, June 22, 2017

Eli Lilly and Company announced completion of a 90 million expansion of its Biotechnology Center in San Diego California Lilly39s new space will help foster and accelerate the discovery of medicines within the company39s core therapeutic areas of immunology diabetes oncology and neurodegeneration as..

Protea introduces new molecular imaging technology

Thursday, June 22, 2017

Protea Biosciences Group Inc announced its development of new technology that enables the direct molecular imaging of the distribution of metabolites and peptides in human clinical tissue samples The results were presented by Dr Erin Seeley Principal Scientist at Protea at the 65th Annual Meeting of..

Phoenix Based BioNovelus Announces a New Product for the Health Disinfectant Industry

Thursday, June 22, 2017

GLOBE NEWSWIRE

Phoenix June 22 2017 GLOBE NEWSWIRE At the recent ExpoMed Show in Mexico City BioNovelus ONOV Chairman and founder Jean Ekobo was proud to introduce the newest addition to the Companys product line Eco Claro is an innovative disinfectant and antiseptic that safely addresses the growing prob..

MariMed Client Opens Nevada Medical Cannabis Cultivation Facility

Thursday, June 22, 2017

GLOBE NEWSWIRE

BOSTON June 22 2017 GLOBE NEWSWIRE MariMed Inc OTCQBMRMD an industry leader in the design development operation funding and optimization of medical cannabis cultivation production and dispensary facilities announced today that their client The Harvest Foundation opened its medical cannabis cul..

Shire Announces EMA Validation of VeyvondiTM Von Willebrand Factor Recombinant Marketing Authorization Application for Treatment of Von Willebrand Disease

Thursday, June 22, 2017

PR Newswire

ZUG Switzerland June 22 2017 PRNewswire VEYVONDI is the first and only recombinant von Willebrand factor treatment for adults with von Willebrand disease the most common inherited bleeding disorder123 Shire plc LSE SHP NASDAQ SHPG the leading biotechnology company focused on serving individuals..

Biohaven Broadens Senior Leadership Team With Veteran Pharma Executives

Thursday, June 22, 2017

PR Newswire

NEW HAVEN Conn June 22 2017 PRNewswire NYSE BHVN Biohaven Pharmaceutical Holding Company Ltd Biohaven and its wholly owned subsidiary Biohaven Pharmaceuticals Inc today announced recent key additions to its senior leadership team as it develops an expanded portfolio of therapeutic candidates acros..

Breakfast Technical Briefing on Biotech Stocks CytRx Keryx Biopharma TG Therapeutics and ZIOPHARM Oncology

Thursday, June 22, 2017

PR Newswire

NEW YORK June 22 2017 PRNewswire If you want a Stock Review on CYTR KERX TGTX or ZIOP then come over to httpdailystocktrackercomregister and sign up for your free customized report today Biotechnology is an industry that focuses on novel drug development and clinical research aimed at treating d..

Lannett Receives Approval For Hydrocodone Bitartrate and Acetaminophen Tablets USP 5 mg300 mg 75 mg300 mg And 10 mg300 mg

Thursday, June 22, 2017

PR Newswire

PHILADELPHIA June 22 2017 PRNewswire Lannett Company Inc NYSE LCI today announced that it received approval from the US Food and Drug Administration FDA of its Abbreviated New Drug Application ANDA for Hydrocodone Bitartrate and Acetaminophen Tablets USP 5 mg300 mg 75 mg300 mg and 10 mg300 mg the..

Enrollment in Phase 12a Study of IONISHTT Rx in Patients with Huntingtons Disease Completed and OpenLabel Extension Study to Open in 2H 2017

Thursday, June 22, 2017

PR Newswire

CARLSBAD Calif June 22 2017 PRNewswire Ionis Pharmaceuticals Inc NASDAQ IONS today announced the completion of enrollment in the Phase 12a randomized placebocontrolled dose escalation study of IONISHTTRx in patients with Huntingtons disease HD Dosing in the final patient cohort continues and Ionis..

DURECT Completes Enrollment in PERSIST Phase 3 trial for POSIMIR

Thursday, June 22, 2017

PR Newswire

CUPERTINO Calif June 22 2017 PRNewswire DURECT Corporation Nasdaq DRRX today announced that patient enrollment has been completed in PERSIST the pivotal Phase 3 clinical trial of POSIMIR SABERBupivacaine an investigational locally acting nonopioid analgesic intended to provide up to three days of..

Linguamatics announces University of Pennsylvania Health System as latest Enterprise NLP client

Thursday, June 22, 2017

PR Newswire

CAMBRIDGEEngland BOSTON June 22 2017 PRNewswire Market leading Natural Language Processing NLP text analytics provider Linguamatics today announced the implementation of the Linguamatics Health enterprise NLP platform powered by I2E at the University of Pennsylvania Health System for the extract..

Nordic Nanovector ASA Mandatory Notification of Trade Primary Insider

Thursday, June 22, 2017

PR Newswire

OSLO Norway June 22 2017 PRNewswire On 22 June 2017 Luigi Costa the CEO of Nordic Nanovector ASA purchased 2000 shares in the company at an average share price of NOK 8597 per share Following this transaction Luigi Costa owns 81115 shares in the Company and holds 1338106 options This information..

Bausch Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International

Thursday, June 22, 2017

PR Newswire

20000 Canadian Consumers Voted Across Multiple Categories for MostTrusted Consumer Packaged Goods Brands LAVAL Quebec June 22 2017 PRNewswire Valeant Pharmaceuticals International Incs NYSE VRX and TSX VRX wholly owned subsidiary Bausch Lomb a leading global eye health company today announced..

Canopy Biosciences Announces Distribution Agreement with Cosmo Bio for Japan Life Science Market

Thursday, June 22, 2017

PR Newswire

ST LOUIS June 22 2017 PRNewswire Canopy BiosciencesTM LLC Canopy Biosciences an emerging provider of gene editing and personalized medicine technologies announced a distributor agreement with Cosmo Bio Co Ltd Cosmo Bio for its TUNR Flexible Gene Editing technology in Japan Cosmo Bio is one of Japa..

Trovagene Announces Agreement with Global Biopharmaceutical Company to Utilize Trovera ctDNA Tests and Services in Cancer Clinical Trials

Thursday, June 22, 2017

PR Newswire

SAN DIEGO June 22 2017 PRNewswire Trovagene Inc NASDAQTROV a precision medicine biotechnology company today announced it has entered into an agreement with a worldwide premier biopharmaceutical company to provide Trovera urine circulating tumor DNA ctDNA biomarker tests and services ..

Puration Announces Pending Acquisition of 1 Million Annual Revenue Grow Operation With Plan to Expand to 16 Million

Thursday, June 22, 2017

PR Newswire

DALLAS June 22 2017 PRNewswire Puration Inc OTC PURA today announced the Company has entered into a letter of intent agreement to acquire First Choice Nursery which has an existing twentyfive greenhouse facility The company has the opportunity to expand to an additional 400 irrigated greenhouse ..

French health system approves reimbursement of QIAGENs QuantiFERON latent TB test

Thursday, June 22, 2017

PR Newswire

HILDEN Germany and PARIS June 22 2017 PRNewswire QIAGEN NV NASDAQ QGEN Frankfurt Prime Standard QIA today announced that Frances Ministry of Health and Social Affairs has approved reimbursement by the national health insurance system for QIAGENs QuantiFERONTB Gold Plus QFTPlus to screen atrisk in..

Johnson Johnson Releases 2016 Health for Humanity Report

Thursday, June 22, 2017

PR Newswire

NEW BRUNSWICK NJ June 22 2017 PRNewswire Johnson Johnson has released its 2016 Health for Humanity Report sharing progress on environmental social and governance measures which advance the Companys mission to profoundly improve the course of health for humanity Our Johnson Johnson Health for..

DelMar Pharmaceuticals Receives Institutional Review Board Approval for Pivotal Phase 3 Clinical Trial of VAL083 in Refractory GBM

Thursday, June 22, 2017

PR Newswire

VANCOUVER British Columbia and MENLO PARK Calif June 22 2017 PRNewswire DelMar Pharmaceuticals Nasdaq DMPI DelMar and the Company a biopharmaceutical company focused on the development of new cancer therapies today announced it has received Institutional Review Board IRB approval to conduct its p..

Breathe Fresh with Auzair

Wednesday, June 21, 2017

Bussinesswireind

Business Wire IndiaRev Up with AuzairAuzair a leading Australian firm providing fresh air in stored bottles has launched its fresh air bottles in India to help people experience a healthier life with pure Australian fresh air The bottle comes in two sizes 75 Liters and 15 Liters The price of the fr..